Sign In
Buy HALO
$69.82
+3.54 (+5.34%)
At Close: Jun 03, 2026
Halozyme Reports First Quarter 2020 Results
08:01pm, Monday, 11'th May 2020
Halozyme Therapeutics, Inc. (NASDAQ: HALO) today reported financial results for the first quarter ended March 31, 2020 and provided an update on its recent corporate activities and outlook.
Halozyme Therapeutics (HALO) Stock Is Absurdly Cheap Right Now
03:50pm, Monday, 11'th May 2020
Artisan Mid Cap Fund recently released its Q1 2020 Investor Letter, a copy of which you can download below. The fund posted a return of -11.55% for the quarter (investor class), outperforming their be
Halozyme Therapeutics shares are trading lower after the company reported worse-than-expected Q1 EPS and sales results.
12:00am, Monday, 11'th May 2020The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
12:00am, Sunday, 10'th May 2020
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB)...
Will Halozyme Therapeutics Continue to Surge Higher?
02:34pm, Friday, 08'th May 2020
As of late, it has definitely been a great time to be an investor Halozyme Therapeutics
Halozyme To Present At The Bank Of America Securities 2020 Healthcare Conference
12:01pm, Thursday, 07'th May 2020
Halozyme Therapeutics, Inc. (NASDAQ: HALO), will participate in the Bank of America Securities 2020 Healthcare Conference. This conference is being hosted virtually. Dr. Helen Torley, president and ch
EXUMA Biotech Is 'Revolutionizing CAR-T Therapy,' Increasing Patient Access, CEO Says
12:00am, Wednesday, 06'th May 2020
EXUMA Biotech is focused on developing a Chimeric Antigen Receptor (CAR)-T cell product for solid tumors.
Chairman and CEO Dr. Greg Frost spoke with Benzinga about patient...
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks hitting 52-week highs May 5.)
Arcturus Therapeutics Ltd (...
Attention Biotech Investors: Mark Your Calendar For These May PDUFA Dates
12:00am, Sunday, 03'rd May 2020
April turned out to be a productive month in terms of drug approvals, with the FDA issuing positive verdicts on almost all applications for which decisions were due. The month saw...
Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that its collaborator Janssen Biotech, Inc. (Janssen) has received approval from the U.S. Food and Drug Administration (FDA) for DARZALEX FAS
Is Halozyme Therapeutics (NASDAQ:HALO) A Risky Investment?
12:50pm, Friday, 01'st May 2020
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs May 1.) * Arcturus Therapeutics Ltd (NASDAQ: ARCT) * AstraZe
